BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 23162861)

  • 1. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.
    Wu CY; Chen YJ; Ho HJ; Hsu YC; Kuo KN; Wu MS; Lin JT
    JAMA; 2012 Nov; 308(18):1906-14. PubMed ID: 23162861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
    Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
    Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
    Young SH; Chau GY; Lee IC; Yeh YC; Chao Y; Huo TI; Su CW; Lin HC; Hou MC; Lee MH; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):218-229. PubMed ID: 31104872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study.
    Wang JP; Kao FY; Wu CY; Hung YP; Chao Y; Chou YJ; Li CP
    Cancer; 2015 May; 121(9):1446-55. PubMed ID: 25537961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
    Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
    Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
    JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: A multicenter study.
    Qi W; Shen J; Dai J; Wu Y; Zhang Y; Leng S; Gao F; Ran S; Peng W; Zhang X; Wen T; Li C
    Cancer Med; 2021 Dec; 10(23):8421-8431. PubMed ID: 34643050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.
    Lee PC; Yeh CM; Hu YW; Chen CC; Liu CJ; Su CW; Huo TI; Huang YH; Chao Y; Chen TJ; Lin HC; Wu JC
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):874-883. PubMed ID: 27541812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
    Li MR; Yi SH; Cai CJ; Yi HM; An YL; Wei M; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):271-4. PubMed ID: 21586225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.
    Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):64-71. PubMed ID: 15017634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
    Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
    Chen VL; Yeh ML; Le AK; Jun M; Saeed WK; Yang JD; Huang CF; Lee HY; Tsai PC; Lee MH; Giama N; Kim NG; Nguyen PP; Dang H; Ali HA; Zhang N; Huang JF; Dai CY; Chuang WL; Roberts LR; Jun DW; Lim YS; Yu ML; Nguyen MH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):44-54. PubMed ID: 29797518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.
    Hung IF; Wong DK; Poon RT; Fong DY; Chui AH; Seto WK; Fung JY; Chan AC; Yuen JC; Tiu R; Choi O; Lai CL; Yuen MF
    PLoS One; 2016; 11(2):e0148493. PubMed ID: 26901762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
    Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH
    Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
    Yeh YC; Liu CJ; Kuo RN; Lai CL; Shau WY; Chen PJ; Lai MS
    PLoS One; 2014; 9(7):e102051. PubMed ID: 25025231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.